Denali Therapeutics Inc. (DNLI) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Denali Therapeutics Inc. (DNLI) closed at USD 17.87 on 2026-10-14, a change of +5.6 % over the past year, with a market capitalization of USD 2.93B.

Denali Therapeutics Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Denali Therapeutics Inc. key figures

Previous close

USD 17.87 (2026-10-14)

1-year change

+5.6 %

Market cap

USD 2.93B

Enterprise value

USD 2.26B

P/E ratio (trailing)

-6.48

P/E ratio (forward)

-7.59

EPS (trailing)

-2.83

EPS (forward)

-2.42

PEG ratio

n/a

Price to book

3.51

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

8.91

Employees

503

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Denali Therapeutics Inc.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Denali Therapeutics Inc. and compare it with other stocks.